Drug General Information
Drug ID	D0LP2H
Former ID	DNC011904
Drug Name	OXAMATE
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[533540]
Structure		Download 2D MOL 3D MOL
Formula	C2H3NO3
Canonical SMILES	C(=O)(C(=O)O)N
InChI	1S/C2H3NO3/c3-1(4)2(5)6/h(H2,3,4)(H,5,6)
InChIKey	SOWBFZRMHSNYGE-UHFFFAOYSA-N
PubChem Compound ID	974
Target and Pathway
Target(s)	4-aminobutyrate aminotransferase, mitochondrial	Target Info	Inhibitor	[533540]
BioCyc Pathway	GABA shunt
	Valine degradation
	Beta-alanine degradation
	4-aminobutyrate degradation
KEGG Pathway	Alanine, aspartate and glutamate metabolism
	Valine, leucine and isoleucine degradation
	beta-Alanine metabolism
	Propanoate metabolism
	Butanoate metabolism
	Metabolic pathways
	GABAergic synapse
PANTHER Pathway	Aminobutyrate degradation
	Pyrimidine Metabolism
	Gamma-aminobutyric acid synthesis
PathWhiz Pathway	Aspartate Metabolism
	Glutamate Metabolism
	Beta-Alanine Metabolism
	Valine, Leucine and Isoleucine Degradation
	Propanoate Metabolism
WikiPathways	GABA synthesis, release, reuptake and degradation
	Alanine and aspartate metabolism
References
Ref 533540	J Med Chem. 1982 Feb;25(2):113-6.Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist.
Ref 533540	J Med Chem. 1982 Feb;25(2):113-6.Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.